At the Pharmaceutical Contract Management Group (PCMG) annual conference this month, representatives from CROs and pharma companies sat down to discuss which industry was leading in innovation. In one corner are CROs, whose proponents emphasized their recent progress in better forecasting trial budgets. In another, pharma bigwigs fired back at CROs, saying they aren't transparent enough, among other points. More from the intense discussion (check out some of the highlighted quotes), can be read at PharmExec. More